14 results
8-K
EX-3.2
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
such reserve in the manner in which it was created.
ARTICLE VIII
RATIFICATION
Any transaction, questioned in any lawsuit on the ground of lack
8-K
EX-1.1
PNT
POINT Biopharma Global Inc.
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
or the transactions contemplated hereby. The parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any lawsuit, action … such lawsuit, action or other proceeding brought in any such court has been brought in an inconvenient forum.
17. Counterparts. This Agreement may
S-3
EX-1.2
PNT
POINT Biopharma Global Inc.
1 Jul 22
Shelf registration
4:13pm
or the transactions contemplated hereby. The parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any lawsuit, action … such lawsuit, action or other proceeding brought in any such court has been brought in an inconvenient forum. The Company irrevocably designates
S-4/A
EX-10.13
7fuh7
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.13
2xy4u2yhm k7yoe7c
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
9f7injldc5hl0qgo
18 Mar 21
Financial Statements and Exhibits
9:08am
424B4
i2ziz4qc2425
9 Jul 20
Prospectus supplement with pricing info
4:46pm
S-1/A
r0vo huoi4x
29 Jun 20
IPO registration (amended)
12:00am
S-1
rnw4 jl5ut
15 Jun 20
IPO registration
5:28pm
DRS
icu cv0hvdaftg5hn09
14 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next